4HeblingD, Bodoky G, Gautschi O, et al. Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer ( LARC ) : a randomized, multicenter, phase 1I trial SAKK 41/07 [ J ]. Ann Oncol,2013,24(3) :718-725.
5Wong NY,Eu KW.A defunctioning ileootomy does not prevent clinical anastomotic leak after a low anterior resection:a prospective,comparative study.Dis Colon Rectum,2005,48(11):2076-2079.
6Peeters KC,Tollenaar RA,Marijnen CA,et al.Risk factors for anastomotic failure after total mesorectal excision of rectal cancer.Br J Surg,2005,92(2):211-216.
7Akiyoshi T, Ueno M, Fukunaga Y, et al. Incidence of and risk factors for anastomotic leakage after laparoscopic anterior resection with intracorporeal rectal transection and double- stapling technique anastomosis for rectal cancer. Am J Surg, 2011,202 : 259-264.
8Kruschewski M, Rieger H, Pohlen U, et al. Risk factors for clinical anastomotic leakage and postoperative mortality in elective surgery for rectal cancer. Int J Colorectal Dis, 2007, 22 : 919-927.
9Kang CY, Halabi WJ, Chaudhry OO, et al. Risk factors for anastomotic leakage after anterior resection for rectal cancer. JAMA Surg, 2013,148:65-71.
10Kondrup J, Rasmussen HH, Hamberg O, et al. Nutritional risk screening (NRS 2002 ): a new method based on an analysis of controlled clinical trials. Clin Nutr, 2003,22 : 321-336.
